Výsledky vyhledávání - "Mohammed Atif Ali"

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

Autor: Ulrik M. Mogensen, Lars Køber, Claudio Gimpelewicz, Yanntong Chiang, Pardeep S. Jhund, Kenneth Dickstein, John J.V. McMurray, Mohammed Atif Ali, Søren Lund Kristensen, Georgia Tarnesby, William T. Abraham, Qing Shao

Publikováno v: European Journal of Heart Failure. 20:136-147

Aims Because of concerns about the safety of aliskiren in patients with diabetes, study treatment was stopped prematurely in the Aliskiren Trial of Minimizing OutcomeS for Patients with HEart failuRE (ATMOSPHERE). We examined outcomes and treatment e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcda4d4d9e5de6c3e29be3b45362a59c
https://doi.org/10.1002/ejhf.896

Zobrazit plný text záznamu

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

Autor: Myron H. Weinberger, James Jin, Deborah L. Keefe, Christian M. Constance, Brent M. Egan, Karl Andersen, Mohammed Atif Ali

Publikováno v: Journal of Hypertension. 26:589-599

OBJECTIVES: This double-blind study compared long-term efficacy, safety and tolerability of the oral direct renin inhibitor aliskiren and the angiotensin-converting enzyme inhibitor ramipril alone and combined with hydrochlorothiazide in patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb08a9d5559f2f31a240c1eb331d730
https://doi.org/10.1097/hjh.0b013e3282f3ad9a

Zobrazit plný text záznamu

Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension

Autor: Mohammed Atif Ali, James Jin, Christian C. Constance, Margaret F. Prescott, Karl Andersen, Deborah L. Keefe, Myron H. Weinberger

Publikováno v: Journal of the Renin-Angiotensin-Aldosterone System, Vol 10 (2009)

Introduction. This subgroup analysis assessed the effects of treatment based on the direct renin inhibitor, aliskiren, or the angiotensin-converting enzyme inhibitor, ramipril, on plasma renin activity (PRA), plasma renin concentration (PRC) and othe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7517d4aee8938cef822365af8aaa4cbb
https://pubmed.ncbi.nlm.nih.gov/19617271

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání